Products

MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)

Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)

High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

Influenza Antiserum A/Singapore/1/57 (H2)

Influenza anti B/Yamanashi/166/98 Serum

Diphtheria Antitoxin Human IgG

Botulinum Type A-E Antitoxin, Human Serum

Influenza anti- A/Chick/Scotland/59 (H5N1) Serum

Influenza Antigen B/Johannesburg/5/99

Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)

Influenza anti-B/Johannesburg/5/99/ Serum

Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)

Interferon Beta SER17 Mutein (Human, rDNA derived)

Interferon Beta (Human, Fibroblast-derived, Glycosylated)

Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)

Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody

Interleukin-17 (Human rDNA derived)(WHO Reference Reagent)

Influenza anti B/Guangdong/120/2000 Serum

Influenza anti A/Panama/2007/99 (H3N2) HA serum

Botulinum type F antitoxin, equine

Botulinum type C antitoxin, equine

Botulinum Antitoxin Equine Type D

Botulinum type G antitoxin, equine

Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody

Anti-Meningococcal Serosubtype P1.16 mAb

Influenza Antigen B/Guangdong/120/2000

Anti-Toxoplasma IgG, Human(International Standard)

Anti-Parvovirus B19, plasma, human(2nd International Standard)

Influenza Virus infectious B/Hawaii/10/01

Influenza Antigen A/New Caledonia/20/99

Influenza anti A/Panama/2007/99 Serum

Anti-Meningococcal Serosubtype P1.15 mAb

Anti-Meningococcal Serosubtype P1.4 mAb

Anti-Meningococcal Serosubtype P1.2 mAb

Anti-Meningococcal Serotype P2.2a mAb

Anti-Japanese Encephalitis Virus Plasma, Human

Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human

Factor XIII Plasma, Human (1st International Standard)

HIV (antibody), 1st International Reference Panel

IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent)

IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent)

Biotinylated Brad-5 (Bio-Brad-5)

Tetanus Toxoid (Non-Adsorbed)

Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(WHO Reference Reagent)

Influenza Antiserum A/chick/Italy/1347/99 (H7N1)

Anti-Meningococcal Serotype P3.4 mAb

Anti-Meningococcal Serotype P3.15 mAb

Botulinum Antitoxin Equine Type E

Anti-Meningococcal Serosubtype P1.3 mAb

Influenza Antigen A/New Caledonia/20/99

Influenza anti A/Panama/2007/99 Serum

Protein C Plasma, Human(2nd International Standard)

HTLV-1 (antibody) Monitor Sample

Influenza anti B/Shangdong/9/97 Serum

Anti-Meningococcal Serosubtype P1.1 mAb

Thrombopoietin ( Human rDNA derived)

Anti-Meningococcal Serosubtype P1.14 mAb

Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent)

Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent)

Anti-HPA-1a (International Standard)

Anti-B minimum potency reference preparation(International Standard)

Vitamin B12, Serum Folate and holoTC (International standard)

Anti-Meningococcal Serotype P3.21 mAb

Anti-A minimum potency reference preparation(International Standard)

Anti-HPA-3a(minimum potency)(WHO Reference Reagent)

Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)

Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent)

Anti-Meningiococcal Serosubtype P1.6 mAb

Influenza anti A/Wyoming/03/03 Serum

Influenza Antigen A/Wyoming/03/03

Anti-Meningococcal Serosubtype P1.10 mAb

Anti-Meningococcal Serosubtype P1.5 mAb

Protein S, Plasma, Human(2nd International Standard)

Anti-Meningococcal Serosubtype P1.13 mAb

Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum

Influenza Antiserum A/chick/Germany/N/49

Influenza Antigen A/New Caledonia/20/99 (IVR-116)

Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)

Anti-Meningococcal Serosubtype P1.12 mAb

Influenza Virus infectious NYMC X-147

TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent)

Influenza Virus infectious A/Wellington/1/2004

Influenza Virus infectious IVR-139

Plasmodium falciparum DNA for NAT Assays(1st International Standard)

Anti-Meningococcal Serotype P3.1 mAb

Influenza Antigen B/ Jiangsu/10/2003

Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004

Influenza anti B/ Neuraminidase Serum

Influenza anti B/Jiangsu/10/2003 HA Serum

Anti-Meningococcal Serogroup W-135 mAb

Anti-Meningococcal Serosubtype P1.19 mAb

Protein C Concentrate, Human(1st International Standard)

Influenza anti A/New Caledonia/20/99 HA Serum

Influenza anti A/New York/55/2004 HA Serum

Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)

Influenza Virus infectious NYMC BX-7

Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent)

Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).

Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)

Anti-human papillomavirus type 16 serum (1st International Standard)

Alpha-1-Antitrypsin, plasma derived(1st International standard)

Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody

Anti Meningococcal Serotype P2.2b Monoclonal Antibody

Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)

Influenza anti A/Wisconsin/67/2005 Serum

Influenza anti B Neuraminidase Serum

Influenza Virus infectious IVR-116

Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)

Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)

Pertussis Antiserum(human)1st IS-WHO international Standard.

Pertussis Antiserum (Human) 1st WHO Reference Reagent

Influenza Virus infectious 1 VR-142

Antithrombin Concentrate, Human (3rd International Standard)

Influenza Antigen A/New Caledonia/20/99

Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)

Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)

Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)

Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)

SARS CoV-1 spike S1 protein

Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)

Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum

Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23

Influenza Virus infectious IVR-145,

Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)

Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum

Human Plasma Anti-Influenza H5N1 (1st International Standard)

Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)

Influenza anti B/Malaysia/2506/2004-HA Serum

Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)

Diphtheria Toxoid (Adsorbed) (4th International Standard)

RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent)

Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”

BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)

BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)

BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)

Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)

Monitor sample for HBsAg 0.05IU/ml

Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml

Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6

Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques

Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques

Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent)

Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)

Meningococcal Group C Polysaccharide

Unfractionated Heparin (6th I.S.)

Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60

Influenza antiserum A/Anhui/1/05 (H5)

Influenza Virus infectious NYMC X-171B

Blood Coagulation Factor VIII Concentrate (8th I.S.)

Influenza Virus infectious NIB-50

Influenza Virus infectious IVR-149

QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1

Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)

Influenza Virus Infectious NIBRG-91 (H9N2)

Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques

Influenza Anti N1 Neuraminidase Serum SH485

Influenza Virus Infectious B/Florida/4/2006

Influenza Antigen B/Florida/4/2006

Influenza antiserum A/Anhui/1/05 (H5)

Influenza Virus Infectious NIBRG-12 (H5N1)

Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1)

Fragile X Syndrome gDNA (1st International Genetic Reference Panel)

Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)

Human Coxsackie B4 for Nucleic Acid Amplification Techniques

Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques

Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques

Influenza Antigen B/Malaysia/2506/2004

Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)

Thyroid Stimulating Antibody (2nd I.S.)

Influenza Antigen A/HongKong/1073/99 (H9N2)

Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)

Meningococcal Serogroup C polysaccharide (1st International Standard)

Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)

Tetanus Toxoid Adsorbed (4th International Standard)

Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91

Streptodornase (2nd International Standard)

Influenza anti A/Brisbane/10/2007- like HA serum

Influenza Virus Infectious NIBRG-107 VE2 30480

Influenza Virus Infectious NIBRG-63 VE2 30500 (H7N1)

Influenza Virus Infectious NIBRG-109 VE2 30490

C1- Inhibitor, Concentrate (1st International Standard)

Antithrombin, Plasma (3rd International Standard)

C1 Inhibitor (Plasma)(1st International Standard)

Sex Hormone Binding Globulin.(2nd International Standard)

Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107

Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))

Influenza Virus Infectious B/Brisbane/33/2008 30720 E5

Influenza Virus Infectious IVR-148

Influenza virus infectious NYMC X-175C

Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing

Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing

Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing

Influenza antiserum A/Japan/305/57 (H2)

Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109

Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)

Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)

Influenza Virus Infectious NIBRG-122

Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing

Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)

Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)

Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)

Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)

Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)

Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody

Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)

Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)

VWF Factor Concentrate (2nd International Standard)

Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14

Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)

Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)

Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)

Human anti-Haemophilus influenzae b reference serum

Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)

Influenza Virus Infectious IVR-153

Fibrinogen Concentrate (B)(2nd International Standard)

Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)

Fibrinogen Plasma (D)(3rd International Standard)

GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived

Influenza Virus Infectious NIBRG-121xp

Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)

Influenza Virus Infectious NYMC X-185

Influenza Virus Infectious NIB-64

Anti-Human Neutrophil Antibody 1a WHO Reference Reagent

Pro-Insulin, human (1st International Standard)

Influenza Virus Infectious IVR-155

Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay

Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)

Reteplase Reference Material

Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum

Diphtheria Polyclonal Antibody

Diphtheria Monoclonal Antibody

Tetanus Polyclonal Antibody

Tetanus Monoclonal Antibody

Anti-human papillomavirus[HPV] 18 serum (1st International Standard)

Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].

Oral Poliovaccine Sabin Type 3 reference

Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent

Endotoxin (3rd International Standard)

Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent)

Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)

Influenza Anti N2 Neuraminidase Serum SH395 & SH396

Influenza Anti A/California/7/2009 (N1) NA Serum

Influenza Virus Infectious IVR-158

Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent)

Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent)

Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent)

Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent)

Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)

Factor VII Concentrate (2nd International Standard)

Influenza Antigen A/California/7/2009-like(NIB-74)

Diphtheria Antitoxin Human IgG(1st International Standard)

4th WHO International Standard for HBV DNA for NAT

BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent)

Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)

pCAGGS-SARS-CoV-2-Spike

VeroE6/TMPRSS2

SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020

pCAGGS_SARS-CoV-2_Spike D614G

pCAGGS-SARS-CoV-2-Spike Bristol Deletion

Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020

Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020

pCRII-SARS-CoV-2 (5'UTR-NSP2)

pCRII-SARS-CoV-2 (NSP4-NSP8)

pCRII-SARS-CoV-2 (NSP4-NSP8)

pCRII-SARS-CoV-2 (NSP15-NSP16)

pCRII-SARS-CoV-2 (ORF3a-ORF6)

SARS-CoV-2 infectious virus (CVR-GLA 1)

SARS-CoV-2 infectious virus(CVR-GLA 2)

SARS-CoV-2 infectious virus(CVR-GLA 3)

VeroE6-ACE2

VeroE6-ACE2-TMPRSS2

A549-ACE2-TMPRSS2

A549-ACE2 Clone8

A549-ACE-2 Clone 8-TMPRSS2

SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020

HEK293T-ACE2-TMPRSS2

Anti-SARS-CoV-2 Nucleocaspid protein (CR3009)

Anti-SARS-CoV-2 Nucleocapsid protein (CR3018)

Anti-SARS-CoV-2 Nucleocapsid protein (CR3009 Human/Mouse HC)

VOC-202012/01 (B.1.1.7 lineage) lot 26012021

SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4

pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021

pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021

4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2

Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021

SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021

SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage)

SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage + E484K)

SARS-CoV-2 Kappa (B.1.617.1 lineage

SARS-CoV-2 Delta (AY.1 sub-lineage)

SARS-CoV-2 Mu (B.1.621 lineage)

Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage)

Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage

Inactivated (acetic acid + heat) SARS-CoV-2 Gamma (P.1 lineage)

0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage)

0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage)

SARS-CoV-2 Nucleocapsid protein (His tagged)

SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged)

SARS-CoV-2 Omicron (lineage B.1.1.529)

Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage)

SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022

SARS-CoV-2 Omicron (BA.2)

IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)

Influenza Virus infectious NYMC X-187

Factors II and X Concentrate (4th International standard)

Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)

Erythropoietin, recombinant, for Bioassay (3rd International Standard)

(3rd International Standard) Low Molecular Weight Heparin

High Molecular Weight Urokinase(2nd International Standard)

Influenza anti-A/Perth/16/2009 HA Serum

Anti-human CD4 FITC conjugated 0.5ml

Biosynthetic Human Insulin (2nd WHO international Standard)

Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent)

Chagas Antibody Reference Panel ( 1st International Standard)

Influenza Virus Infectious NIB-79

Influenza Virus Infectious B/Texas/6/2011

Immunoglobulin E(IgE) human serum (3rd International Standard)

Viral Multiplex Reference

Influenza Virus Infectiious NYMC BX-49

QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1

Influenza Virus Infectious NYMC X-217

International Standard for IPV 12/104 (3rd International Standard)

Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)

Influenza Antigen B/Wisconsin/1/2010 (cell derived)

Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)

Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)

Influenza anti-A/Victoria/361/2011-like HA serum

Influenza anti-B/Wisconsin/1/2010-like HA serum

Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1)

Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)

Methylated Human Serum Albumin (mHSA)

Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard)

Influenza virus infectious B/Wisconsin/1/2010 34490 E5

Influenza virus infectious NYMC BX-39

Influenza Virus infectious IVR-165

Parvovirus B19 (3rd International Standard)

HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)

HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)

Vi polysaccharide of C freundii WHO 1st International Standard

ADAMTS 13 Plasma (1st International Standard)

2nd Pneumococcal QC Serum Panel

Diphtheria Toxin 1Lf/ml

Anti-meningococcal serogroup Y monoclonal antibody

Influenza Virus Infectious B/Brisbane/36/2012

Influenza Virus Infectious NYMC BX-51C

Negative Control IVIG (for use with IVIG and Anti-D)

Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)

QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1

Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)

Influenza Antigen B/Massachusetts/02/2012

Anti-Meningococcal serogroup B monoclonal antibody

Influenza Antigen A/Texas/50/2012 (NYMC X-223)

Influenza Antigen A/Texas/50/2012 (NYMC X-223A)

Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)

Influenza anti-B/Brisbane/60/2008-like HA serum

Influenza Virus Infectious NIBRG-269

Antibodies, Human, to Toxoplasma gondii (4th International Standard).

Influenza Antigen B/Massachusetts/02/2012 (Egg derived)

C-Peptide, Human (1st International Standard).

IVIG + anti-D for use with negative control IVIG

Influenza Antigen B/Massachusetts/02/2012 (Cell Derived)

Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)

Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)

Influenza anti-A/Anhui/1/2013 (N9) NA Serum

Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques

Lupus Anticoagulant (1st International Reference Panel)

Influenza Virus Infectious NIBRG-88

Influenza Anti-A/Texas/50/2012-like HA Serum

Influenza Anti-B/Massachusetts/02/2012-like HA Serum

Influenza Virus Infectious NIB-74

Influenza Virus Infectious NIB-74xp

TNF Rec II- FC Fusion protein (1st International Standard)

Plasmin (4th International Standard)

Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)

HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)

Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal

Polio Anti Sabin type 1 (inactivated) Serum

Polio Anti Sabin type 2 (inactivated) serum

Polio Anti Sabin type 3 (inactivated) serum

Influenza virus Infectious NIB-85. 36210 E5

Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4

Influenza antigen B/Brisbane/60/08

Anti-EV71 serum LOW (WHO Reference Reagent)

Tetanus Immunoglobulin, Human (2nd WHO International Standard)

FEIBA Concentrate 2nd NIBSC Working Reference Standard

Meningococcal serogroup A polysaccharide (1st WHO International Standard).

Influenza virus infectious NIBRG-267 (H7N9)

Influenza Virus Infectious NIBRG-268 (H7N9)

Influenza virus infectious NYMC X-223A

Influenza virus infectious. NYMC x-233

Influenza virus infectious NYMC X-233A

Meningococcal serogroup A polysaccharide

Influenza Virus Infectious NYMC X-223

QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1

QCRHBeQC1 Anti-HBe Control Serum: sample1

QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2

QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5

QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1

QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3

Human Papillomavirus (HPV) 11 DNA (1st International Standard)

Human Papillomavirus (HPV) Type 45 DNA (1st International Standard)

Influenza virus infectious. NYMC BX-51B

JC Virus (JCV) DNA (1st International Standard)

Influenza virus infectious NYMC X-179A

Influenza virus infectious B/Massachusetts/2/2012

1st International Standard for Anti EV71 Serum Human

Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011)

Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)

Human Blood Factor IX Concentrate (5th International Standard).

Meningococcal group X polysaccharide (1st WHO International Standard)

High titre anti-A in IVIG working reference reagent

Botulinum Type A Antitoxin, Equine

HBV,HCV,HIV Multiplex

Influenza Antigen A/Puerto Rico/8/34 (HINI)

Influenza virus infectious NYMC X-247

Biological activities of Rituximab WHO 1st International Standard

BK Virus (BKV)(1st International Standard)

Influenza virus infectious. A/Switzerland/9715293/2013

Influenza Virus Infectious A/South Australia/55/2014

Influenza Virus Infectious A/Stockholm/6/2014

Influenza Virus Infectious. A/Norway/466/2014

Influenza Virus Infectious IVR-175

Recombinant Tissue factor

Influenza Antigen A/Switzerland/9715293/2013 (NIB88)

Human Papillomavirus (HPV) Type 6 DNA (1st International Standard)

Human Papillomavirus (HPV) Type 31 DNA (1st International Standard)

Human Papillomavirus (HPV) Type 33 DNA (1st International Standard)

Human Papillomavirus (HPV) Type 52 DNA (1st International Standard)

Human Papillomavirus (HPV) Type 58 DNA (1st International Standard)

Influenza Antigen B/Brisbane/9/2014 (Egg Derived)

High titre anti-A and anti-B in serum (WHO Reference Reagent).

Influenza Virus Infectious NYMC X-243 40180 E13

Influenza Virus Infectious IVR-178 40200 E7

Influenza Virus Infectious NIB-88

Factor IX activated (FIXa) 2nd WHO International Standard

Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625)

Influenza Virus Infectious NIB-91

QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2

QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3

QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1

QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1

Influenza Antigen B/Utah/9/2014 (Cell Derived)

Activated Blood Coagulation Factor X (FXa), Human

Influenza Antigen A/South Australia/55/2014 Cell derived

Ancrod

Bordetella pertussis toxin (20µg). (2nd International Standard)

Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)

Influenza Anti-A Switzerland/9715293/2013-Like HA serum

EBOV RNA NP-VP35-GP in-run control

EBOV RNA VP40-L in-run control

Batroxobin

Influenza Virus Infectious NIB-92

Influenza Virus Infectious NIB-93

Influenza Virus Infectious NYMC X-263

Influenza Virus Infectious NIBRG-306

Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent

Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)

7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate

Influenza Virus Infectious NYMC X-263B

Influenza Virus Infectious NYMC X-263A

Influenza Virus Infectious NYMC X-257A

Influenza Virus Infectious NYMC X-261

Influenza Virus Infectious NYMC BX-53C

Anti-EBOV plasma, human (WHO Reference Reagent)

EBOV RNA NP-VP35-GP (WHO Reference Reagent)

EBOV RNA VP40-L (WHO Reference Reagent)

Influenza Virus Infectious B/Texas/2/2013 41340 E7

Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)

Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)

Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)

Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645)

Influenza Virus Infectious NYMC BX-31

Influenza Virus Infectious A/California/7/2009

1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool

HHV-6 Virus 1st WHO International Standard

CD4 WHO Reference Reagent

ICS Positive Control-Lymphocytes

Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard)

Influenza virus infectious NYMC BX-59B

Sabin monovalent Polio vaccine type 2 (1st International Standard)

Influenza Virus Infectious B/Brisbane/46/2015

Influenza Virus Infectious NYMC BX-35 41950 E11

Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard

QCRLYMEQC1 - Anti-Lyme QC1

QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1

QCRMEASQC1 Anti-Measles QC1

QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1

QCRPARVB19QC1 Anti-Parvovirus B19QC1

Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)

Influenza Virus Infectious A/PR/8/34

Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)

Influenza anti - A/California/7/09 HA serum

Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)

WHO 1st International Reference Panel for Genomic JAK2 V617F

Native Vi polysaccharide (S. Typhi) (1st International Standard)

Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard

Meningococcal Serogroup W Polysaccharide

Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard)

Infliximab (1st International Standard)

Influenza Anti-A/Hong Kong/4801/2014-like HA Serum

Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent)

Influenza Anti - B/Brisbane/60/2008-HA serum

HIV-1 RNA (4th International Standard)

Sabin monovalent Polio vaccine type 1(1st International Standard)

Influenza Virus Infectious NIB-58

OPV reference mOPV 3

7th WHO International Standard for Rabies Vaccine

Meningococcal serogroup Y Polysaccharide

Influenza Virus Infectious NIB-97 42090 E7

HIV-1 P24 Antigen (1st international reference panel)

HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent)

Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)

Influenza Virus Infectious NIB-98 42110 E7

1st International Reference Panel for genomic KRAS codons 12 and 13 mutations

Influenza Virus Infectious X-273

Influenza Virus Infectious IVR-180 42400 E3/D7/E1

Influenza Virus Infectious X-275A 42010 E13

Anti-D Immunglobulin control preparation

Influenza Virus Infectious X-285 42430 ExE1

Antiserum to Respiratory Syncytial Virus WHO 1st International Standard

Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B)

Influenza Virus Infectious X-283A 42420 ExE1

Influenza Virus Infectious X-285A 42440 ExE1

Influenza Antigen A/Singapore/GP1908/2015 (IVR-180)

Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard)

Tetanus Toxoid for use in Flocculation Test (3rd International Standard)

Zika Antibody Working reagent

Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard).

Anti-D Immunoglobulin (Replacement IS)

WHO Anti-EBOV Convalescent Plasma (International Reference Panel)

Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard)

Streptokinase (4th WHO International Standard)

Influenza Virus Infectious NIB-96 41920 E7

Influenza Virus Infectious NYMC X-291 42530 E8

3rd International Standard for Prekallikrein Activator

Influenza Virus Infectious NYMC X-291A 42540 E8

HSV-1

Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard)

Plasmodium falciparum antigens (1st International Standard)

QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices

QCRCMVIgMQC1 IgM Anti-CMV QC1

QCREBVVCAQC1

QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1

QCREBVNEGQC1

Fimbrae monoclonal antibody, clone 1-7

Prostate Specific Antigen (human)(total: PSA-ACT + free PSA)

Prostate Specific Antigen (human) (Free), (2nd WHO International Standard)

Influenza Anti-A/Michigan/45/2015-like HA Serum

HSV-2

Influenza Virus Infectious NYMC BX-63 42790 E10/E1

Influenza Virus Infectious NYMC BX-63A 42780 E10/E1

Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637)

Influenza Virus Infectious NIBRG-375 (H7N9)

Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1)

Influenza Antigen A/Michigan/45/2015 (NYMC X-275)

Influenza Virus Infectious CNIC-1701 42910 E9

Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard)

Influenza Virus Infectious NYMC X-299 42920 E10

Influenza Virus Infectious B/Maryland/15/2016 42800 E5

Influenza Antigen A/Michigan/45/2015 (NYMC X-275)

Influenza Virus Infectious NIB-103 42610 E7

Influenza Virus Infectious NYMC X-297 42940 E11

Influenza Virus Infectious NIB-104

1st International Standard for Darbepoetin

14th British Standard for Coagulation Factor VIII Concentrate, Human.

Influenza Virus Infectious IVR-186 43310 E8

Tumor Necrosis Factor alpha (human rDNA derived)

Adalimumab (1st WHO International Standard)

5% Immunoglobulin (Negative Control)

Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104)

Influenza Virus Infectious NYMC BX-69 43220 E13

Influenza Virus Infectious NYMC BX-69A

Influenza Virus Infectious B/Alabama/2/2017

Influenza Virus Infectious A/Michigan/45/2015 43470 E5

QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1

QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample 2

QCRHBsGQC1-HBsAg Quality Control Serum: Sample1

QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1

QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1

QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1

Influenza Antigen B/Maryland/15/2016

Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A)

Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum

Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186)

Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum

WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4)

1st International Standard for HCT 15 Cancer Genome

WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4)

1st International Standard for MOLT-4 Cancer Genome

Influenza Virus Infectious NIBRG-301 (H5N1)

Influenza Virus Infectious NIBRG-14 (H5N1)

Influenza Virus Infectious NYMC X-307A

Influenza Virus Infectious NYMC X-307

WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis

Pertussis antiserum (human) panel

Bordetella pertussis, pertactin, PRN

WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4)

Influenza Virus Infectious NYMC X-311

1st International Standard for ATDB102 Genome

Influenza Virus Infectious NIB-112 43990 E6

Influenza Virus Infectious A/Switzerland/8060/2017

Influenza anti-B/Colorado/06/2017-like HA serum

Influenza Virus Infectious A/Brisbane/1/2018

2nd International Standard for Diphtheria Antitoxin Equine

Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard)

Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112)

Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311)

Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum

Influenza Virus Infectious NYMC X-275 (Influenza Reagent)

Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9)

West Nile Virus - International Standard

WHO Reference Reagent for West Nile Virus lineage 2 RNA for NAT-based assays

Bevacizumab (1st WHO International Standard)

Anti-HPA 15b minimum potency reagent (WHO Reference Reagent)

Influenza Virus Infectious IVR-190 44250 E12

Influenza Virus Infectious B/Colorado/06/2017 43460 E7

Influenza Virus Infectious NIB116-B 44230 E5

Influenza Virus Infectious A/Brisbane/02/2018

Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1)

Influenza Virus Infectious NYMC X-327 44280 E17

Influenza Virus Infectious A/Kansas/14/2017 43880 E8

Human Chorionic Gonadotropin (hCG) (6th International Standard)

Von Willebrand Factor Concentrate (WHO 3rd International Standard)

Anti CMV QC1 QCRCMVQC1

QCRNEGQC1-Negative Quality Control Serum: Sample1

QCREBVIgMQC1

QCRLYMEIgMQC1 IgM Anti-Lyme QC1

Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701)

Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2)

Influenza Virus Infectious IVR-195 44300 E9

Trastuzumab (1st WHO international Standard)

Influenza Virus Infectious NIB-110

Anti-Human Neutrophil Antibody 3a WHO Reference Reagent

1st WHO Plasmodium Vivax Antigen (LDH)

Ferritin (Human, Recombinant)

Influenza Virus Infectious X-327 A 44310 E18

Influenza Virus Infectious CNIC-1903

Influenza Virus Infectious CNIC-1902 44320 E10

Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum

Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2)

Panel of recombinant antibody controls for Cytokine Release Assays

Influenza Virus Infectious A/California/7/09 44430 E6

VZV Nucleic acid amplification techniques (1st WHO International Standard)

Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard)

Influenza Virus Infectious BVR-11

Influenza Virus Infectious IVR-197 (H3N2) 44850 E14

Influenza Virus Infectious B/Victoria/705/2018

1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human)

Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody

3rd International Standard Thrombin

Influenza Virus Infectious IVR-202 (H3N2) 44880 E10

Influenza Virus Infectious B/Brisbane/35/2018

1st WHO Reference Reagent for anti-malaria (Plasmodium Vivax) human plasma

Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived)

Influenza Virus Infectious X-181 45030 E8

Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage)

Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived)

Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2)

Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716)

Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11

Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58

Influenza Virus Infectious A/South Australia/34/2019

Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4

Influenza Antigen B/Washington/02/2019 9B Victoria Lineage)

British Working Standard for Anti-HCV

British Working Standard for Anti HCV 1 in 8 Dilution

Influenza Virus Infectious BX-85C 45230 E13

Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1

Anti-thyroid peroxidase antibodies (1st WHO International Standard)

Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5

Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1)

Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived)

Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1)

Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728)

Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734)

Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742)

Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736)

Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum (Sheep 743, 744, 745, 746, 747, 748)

QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4

Anti-Rubella QC2

Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1

Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1

Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2)

SARS-CoV-2 (NAT)

IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2

Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2)

Influenza Virus Infectious BX-57 45430 E4/E10/E1

Working Reagent for SARS-CoV-2 RNA

First WHO International Standard for SARS-CoV-2 RNA

First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays

NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant

Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1

Monitor Sample for Anti HTLV-II

NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT)

Influenza A (H1N1) Panel

Influenza A (H3N2) Panel

Influenza B Panel

RSV A Panel

RSV B Panel

SARS-CoV-2 Panel

Anti-Lassa Virus Antibodies (1st International Standard)

Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1

Follicle Stimulating Hormone (3rd International Standard)

Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1

Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754)

Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720

Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730

Influenza Virus Infectious X-341 + 1P (H3N2)

Nucleic Acid Amplification Technique (NAT) Panel for SARS-CoV-2

SARS-CoV-2 Ag QC

Influenza Virus Infectious X-347 (H3N2)

Influenza Virus Infectious X-347A (H3N2)

WHO International Reference Reagent for GUT Microbiome analysis by NGS (Gut-Mix RR)

WHO Reference Reagent for GUT Microbiome analysis by NGS (DNA-Gut-HiLo)

Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2)

Influenza Virus Infectious IVR-221 (H3N2)

Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2)

QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2

QCRHBsQC1

QCRHIV1QC2 - Anti-HIV Quality Control Serum sample 2

QCRSARSCoV2QC1

QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1

QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1

Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2)

Working Reagent for Lassa virus RNA

‘First WHO International Standard for Lassa virus RNA’

Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2)

Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum

Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum

Influenza Virus Infectious X-357A (H3N2)

Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage)

Influenza Virus Infectious SAN-004A (H3N2)

Influenza Virus Infectious B/Phuket/3073/2013 (B-Yamagata lineage)

Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage)

Influenza Virus Infectious X-359 (H3N2)

Influenza Virus Infectious X-359A (H3N2)

Influenza Virus Infectious BX-93A (B-Victoria Lineage)

Influenza Virus Infectious BX-93B (B-Victoria Lineage)

Influenza Virus Infectious X-353 (H3N2)

Influenza Virus Infectious X-355B (H3N2)

Influenza Virus Infectious X-355A-CL (H3N2)

Meningococcal Capsular Group W polysaccharide

Influenza Virus Infectious A/Tasmania/503/2020 (H3N2)

Influenza Virus Infectious X-361A (H3N2)

Influenza Virus Infectious BX-97A (B-Victoria Lineage)

Influenza Virus Infectious A/Hong Kong/2671/2019

Influenza Virus Infectious IVR-224 (H3N2)

Influenza Virus Infectious IVR-227 (H3N2)

Influenza Virus Infectious A/Darwin/6/2021 (H3N2)

Influenza Virus Infectious A/Darwin/9/2021 (H3N2)

Influenza Virus Infectious BVR-25 (B-Victoria Lineage)

Influenza Virus Infectious BVR-26 (B/Victoria Lineage)

Influenza Virus Infectious B/Austria/1359417/2021 (B/Victoria Lineage)

Influenza Virus Infectious NIB-127 (H3N2)

Influenza Virus Infectious NIB-126 (H3N2)

Tetanus Antitoxin Equine for Flocculation Test (Candidate)

Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1)

Influenza Virus Infectious CNIC-1909 (H1N1)

Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage)

Influenza Virus Infectious B/Michigan/1/2021 (B/Victoria Lineage)

Influenza Virus Infectious IVR-228 (H3N2)

Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580

Influenza Virus Infectious IVR-215 (H1N1)

1st International Standard 2022 Anti-β2GPI IgG 200 IU/Vial

Anti-pneumococcal serotype 1 monoclonal antibody

Anti-pneumococcal serotype 3 monoclonal antibody

Anti-pneumococcal serotype 5 monoclonal antibody

Anti-pneumococcal serotype 6A / 6C monoclonal antibody

Anti-pneumococcal serotype 7F monoclonal antibody

Anti-pneumococcal serotype 8 monoclonal antibody

Anti-pneumococcal serotype 9N monoclonal antibody

Anti-pneumococcal serotype 9V monoclonal antibody

Anti-pneumococcal serotype 10A monoclonal antibody

Anti-pneumococcal serotype 12F monoclonal antibody

Anti-pneumococcal serotype 14 monoclonal antibody

Anti-pneumococcal serotype 18C monoclonal antibody

Anti-pneumococcal serotype 19A monoclonal antibody

Anti-pneumococcal serotype 22F monoclonal antibody

Influenza Virus Infectious A/Michigan/173/2020 (H3N2)

Influenza Virus Infectious SAN-010 (H3N2)

Influenza Antigen A/Darwin/6/2021 (IVR-227) (H3N2)

Influenza Antigen B/Austria/1359417/2021 (BVR-26) (B Victoria Lineage)

Influenza Antigen A/Darwin/9/2021 (IVR-228) (H3N2)

Influenza Antigen A/Darwin/9/2021 (SAN-010) (H3N2)

Influenza Anti-B Neuraminidase Serum (B/Phuket/3073/2013)

Influenza Anti-A/Darwin/9/2021-Like (H3N2) HA Serum

Influenza Anti-B/Austria/1359417/2021 Like (B Victoria Lineage) HA Serum

Influenza Antigen B/Michigan/01/2021

1st International Reference Panel for anti-Lassa fever virus antibodies

Influenza Virus Infectious B/Washington/02/2019 (B-Victoria lineage)

Working Standard for anti-SARS-CoV-2 antibodies

Influenza Virus Infectious A/Victoria/2570/2019 (H1N1)

Influenza Virus Infectious B/Utah/9/2014 (B-Yamagata lineage)

Influenza Virus Infectious BX-59A (B-Yamagata lineage)